BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 9130713)

  • 1. harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L).
    Inohara N; Ding L; Chen S; Núñez G
    EMBO J; 1997 Apr; 16(7):1686-94. PubMed ID: 9130713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins.
    Boyd JM; Gallo GJ; Elangovan B; Houghton AB; Malstrom S; Avery BJ; Ebb RG; Subramanian T; Chittenden T; Lutz RJ
    Oncogene; 1995 Nov; 11(9):1921-8. PubMed ID: 7478623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2.
    Zha H; Aimé-Sempé C; Sato T; Reed JC
    J Biol Chem; 1996 Mar; 271(13):7440-4. PubMed ID: 8631771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BID: a novel BH3 domain-only death agonist.
    Wang K; Yin XM; Chao DT; Milliman CL; Korsmeyer SJ
    Genes Dev; 1996 Nov; 10(22):2859-69. PubMed ID: 8918887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K.
    Han J; Sabbatini P; White E
    Mol Cell Biol; 1996 Oct; 16(10):5857-64. PubMed ID: 8816500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death.
    Yang E; Zha J; Jockel J; Boise LH; Thompson CB; Korsmeyer SJ
    Cell; 1995 Jan; 80(2):285-91. PubMed ID: 7834748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death.
    Reed JC; Zha H; Aime-Sempe C; Takayama S; Wang HG
    Adv Exp Med Biol; 1996; 406():99-112. PubMed ID: 8910675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
    Zhang S; Long A; Link AJ
    ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the BH3 (Bcl-2 homology 3) domain in the regulation of apoptosis and Bcl-2-related proteins.
    Lutz RJ
    Biochem Soc Trans; 2000 Feb; 28(2):51-6. PubMed ID: 10816098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mtd, a novel Bcl-2 family member activates apoptosis in the absence of heterodimerization with Bcl-2 and Bcl-XL.
    Inohara N; Ekhterae D; Garcia I; Carrio R; Merino J; Merry A; Chen S; Núñez G
    J Biol Chem; 1998 Apr; 273(15):8705-10. PubMed ID: 9535847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
    Huang DC; Adams JM; Cory S
    EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL.
    Simonian PL; Grillot DA; Merino R; Nuñez G
    J Biol Chem; 1996 Sep; 271(37):22764-72. PubMed ID: 8798452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members.
    Holmgreen SP; Huang DC; Adams JM; Cory S
    Cell Death Differ; 1999 Jun; 6(6):525-32. PubMed ID: 10381646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the anti-apoptotic mechanism of Bcl-B.
    Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
    Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9.
    Conradt B; Horvitz HR
    Cell; 1998 May; 93(4):519-29. PubMed ID: 9604928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition.
    Shimazu T; Degenhardt K; Nur-E-Kamal A; Zhang J; Yoshida T; Zhang Y; Mathew R; White E; Inouye M
    Genes Dev; 2007 Apr; 21(8):929-41. PubMed ID: 17403773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains.
    Tan KO; Tan KM; Chan SL; Yee KS; Bevort M; Ang KC; Yu VC
    J Biol Chem; 2001 Jan; 276(4):2802-7. PubMed ID: 11060313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway.
    Gillissen B; Essmann F; Graupner V; Stärck L; Radetzki S; Dörken B; Schulze-Osthoff K; Daniel PT
    EMBO J; 2003 Jul; 22(14):3580-90. PubMed ID: 12853473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members.
    Hsu SY; Lin P; Hsueh AJ
    Mol Endocrinol; 1998 Sep; 12(9):1432-40. PubMed ID: 9731710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-B, a novel Bcl-2 family member that differentially binds and regulates Bax and Bak.
    Ke N; Godzik A; Reed JC
    J Biol Chem; 2001 Apr; 276(16):12481-4. PubMed ID: 11278245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.